| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |